These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 26607904)

  • 21. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.
    Roh JL; Kim EH; Jang H; Shin D
    Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways.
    Stander XX; Stander BA; Joubert AM
    Cell Physiol Biochem; 2015; 35(4):1499-526. PubMed ID: 25791820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of two aspects of metabolism in breast cancer treatment.
    Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
    Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
    Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis.
    Zhao X; Li S; Mo Y; Li R; Huang S; Zhang A; Ni X; Dai Q; Wang J
    Oxid Med Cell Longev; 2021; 2021():5173035. PubMed ID: 34712383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
    Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
    Cells; 2019 May; 8(5):. PubMed ID: 31109089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting.
    Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X
    Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
    Kim EH; Shin D; Lee J; Jung AR; Roh JL
    Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
    Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XI-011 enhances cisplatin-induced apoptosis by functional restoration of p53 in head and neck cancer.
    Roh JL; Park JY; Kim EH
    Apoptosis; 2014 Nov; 19(11):1594-602. PubMed ID: 25113507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic modulation of glioblastoma with dichloroacetate.
    Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
    Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
    Lee J; You JH; Shin D; Roh JL
    Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
    Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I
    Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells.
    Kim JS; Lee JH; Jeong WW; Choi DH; Cha HJ; Kim DH; Kwon JK; Park SE; Park JH; Cho HR; Lee SH; Park SK; Lee BJ; Min YJ; Park JW
    Int J Cancer; 2008 Feb; 122(3):672-80. PubMed ID: 17955488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
    Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
    Sun L; Jiang Y; Yan X; Dai X; Huang C; Chen L; Li T; Zhang Y; Xiao H; Yang M; Xiang L; Zhang Y; Chen S; Li S; Chen A; He F; Lian J
    Exp Cell Res; 2021 Sep; 406(1):112755. PubMed ID: 34332981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation.
    Zhou X; Chen R; Yu Z; Li R; Li J; Zhao X; Song S; Liu J; Huang G
    Mol Cancer; 2015 Mar; 14():63. PubMed ID: 25888721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.